Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 519816, 10 pages
http://dx.doi.org/10.1155/2014/519816
Review Article

Magnetic Resonance Spectroscopy: An In Vivo Molecular Imaging Biomarker for Parkinson’s Disease?

1IRCCS Centro Neurolesi “Bonino-Pulejo,” S.S. 113 Via Palermo, Contrada Casazza, 98124 Messina, Italy
2Department of Biomedical Sciences and Morphological and Functional Imaging, University of Messina, 98124 Messina, Italy

Received 8 May 2014; Revised 14 August 2014; Accepted 31 August 2014; Published 11 September 2014

Academic Editor: Yiying Zhang

Copyright © 2014 Rosella Ciurleo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Jankovic, “Parkinson's disease: clinical features and diagnosis,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 4, pp. 368–376, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Obeso, M. C. Rodriguez-Oroz, M. Rodriguez et al., “Pathophysiology of the basal ganglia in Parkinson's disease,” Trends in Neurosciences, vol. 23, supplement 1, no. 10, pp. S8–S19, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Yasuda, Y. Nakata, and H. Mochizuki, “α-Synuclein and neuronal cell death,” Molecular neurobiology, vol. 47, no. 2, pp. 466–483, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Riederer and S. Wuketich, “Time course of nigrostriatal degeneration in Parkinson's disease: a detailed study of influential factors in human brain amine analysis,” Journal of Neural Transmission, vol. 38, no. 3-4, pp. 277–301, 1976. View at Google Scholar · View at Scopus
  5. H. Braak, U. Rüb, D. Sandmann-Keil et al., “Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system,” Acta Neuropathologica, vol. 99, no. 5, pp. 489–495, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Lin, B. D. Ross, K. Harris, and W. Wong, “Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making,” NeuroRx, vol. 2, no. 2, pp. 197–214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Rosen and R. E. Lenkinski, “Recent advanced in magnetic resonance neurospectroscopy,” Neurotherapeutics, vol. 4, no. 3, pp. 330–345, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Ross and S. Bluml, “Magnetic resonance spectroscopy of the human brain,” The Anatomical Record, vol. 265, no. 2, pp. 54–84, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. C. E. Clarke and M. Lowry, “Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy,” European Journal of Neurology, vol. 7, no. 6, pp. 661–665, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. B.-Y. Choe, J.-W. Park, K.-S. Lee et al., “Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy,” Investigative Radiology, vol. 33, no. 8, pp. 450–455, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. J. O'Neill, N. Schuff, W. J. Marks Jr., R. Feiwell, M. J. Aminoff, and M. W. Weiner, “Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease,” Movement Disorders, vol. 17, no. 5, pp. 917–927, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. S. D. Taylor-Robinson, N. Turjanski, S. Bhattacharya et al., “A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease,” Metabolic Brain Disease, vol. 14, no. 1, pp. 45–55, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. M. T. M. Hu, S. D. Taylor-Robinson, K. Ray Chaudhuri et al., “Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 67, no. 1, pp. 20–26, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Lucetti, P. Del Dotto, G. Gambaccini et al., “Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients,” Neurological Sciences, vol. 22, no. 1, pp. 69–70, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. R. M. Camicioli, J. R. Korzan, S. L. Foster et al., “Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia,” Neuroscience Letters, vol. 354, no. 3, pp. 177–180, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. R. M. Camicioli, C. C. Hanstock, T. P. Bouchard, M. Gee, N. J. Fisher, and W. R. W. Martin, “Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson's disease,” Movement Disorders, vol. 22, no. 3, pp. 382–386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. C. A. Davie, G. K. Wenning, G. J. Barker et al., “Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy,” Annals of Neurology, vol. 37, no. 2, pp. 204–210, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. C. J. Cruz, M. J. Aminoff, D. J. Meyerhoff, S. H. Graham, and M. W. Weiner, “Proton MR spectroscopic imaging of the striatum in parkinson's disease,” Magnetic Resonance Imaging, vol. 15, no. 6, pp. 619–624, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Tedeschi, I. Litvan, S. Bonavita et al., “Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration,” Brain, vol. 120, no. 9, pp. 1541–1552, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. C. E. Clarke, M. Lowry, and A. Horsman, “Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy,” Movement Disorders, vol. 12, no. 3, pp. 297–301, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Gröger, G. Chadzynski, J. Godau, D. Berg, and U. Klose, “Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease,” European Radiology, vol. 21, no. 9, pp. 1962–1969, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. B. E. Levin, H. L. Katzen, A. Maudsley et al., “Whole-brain proton MR spectroscopic imaging in Parkinson's disease,” Journal of Neuroimaging, vol. 24, no. 1, pp. 39–44, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. H. R. Griffith, O. C. Okonkwo, T. O'Brien, and J. A. den Hollander, “Reduced brain glutamate in patients with Parkinson's disease,” NMR in Biomedicine, vol. 21, no. 4, pp. 381–387, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. G. Öz, M. Terpstra, I. Tkác et al., “Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations,” Magnetic Resonance in Medicine, vol. 55, no. 2, pp. 296–301, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. U. E. Emir, P. J. Tuite, and G. Öz, “Elevated pontine and putamenal gaba levels in mild-moderate parkinson disease detected by 7 tesla proton MRS,” PLoS ONE, vol. 7, no. 1, Article ID e30918, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Di Costanzo, F. Trojsi, M. Tosetti et al., “Proton MR spectroscopy of the brain at 3 T: an update,” European Radiology, vol. 17, no. 7, pp. 1651–1662, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Kickler, P. Krack, V. Fraix et al., “Glutamate measurement in Parkinson's disease using MRS at 3 T field strength,” NMR in Biomedicine, vol. 20, no. 8, pp. 757–762, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. X. T. Fan, F. Zhao, Y. Ai et al., “Cortical glutamate levels decrease in a non-human primate model of dopamine deficiency,” Brain Research, vol. 1552, pp. 34–40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Chassain, G. Bielicki, C. Keller, J.-P. Renou, and F. Durif, “Metabolic changes detected in vivo by 1H MRS in the MPTP-intoxicated mouse,” NMR in Biomedicine, vol. 23, no. 6, pp. 547–553, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. H.-C. Gao, H. Zhu, C.-Y. Song et al., “Metabolic changes detected by ex vivo high resolution 1H NMR spectroscopy in the striatum of 6-OHDA-induced Parkinson's rat,” Molecular Neurobiology, vol. 47, no. 1, pp. 123–130, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Bagga, A. N. Chugani, K. S. Varadarajan, and A. B. Patel, “In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment,” Journal of Neurochemistry, vol. 127, no. 3, pp. 365–377, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. A. H. V. Schapira, M. Gu, J.-W. Taanman et al., “Mitochondria in the etiology and pathogenesis of Parkinson's disease,” Annals of Neurology, vol. 44, no. 3, pp. S89–S98, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. B. C. Bowen, R. E. Block, J. Sanchez-Ramos et al., “Proton MR spectroscopy of the brain in 14 patients with Parkinson disease,” The American Journal of Neuroradiology, vol. 16, no. 1, pp. 61–68, 1995. View at Google Scholar · View at Scopus
  34. S. J. G. Lewis, J. M. Shine, S. Duffy, G. Halliday, and S. L. Naismith, “Anterior cingulate integrity: executive and neuropsychiatric features in Parkinson's disease,” Movement Disorders, vol. 27, no. 10, pp. 1262–1267, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Nie, Y. Zhang, B. Huang et al., “Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment,” Parkinsonism and Related Disorders, vol. 19, no. 3, pp. 329–334, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Brand, C. Richter-Landsberg, and D. Leibfritz, “Multinuclear NMR studies on the energy metabolism of glial and neuronal cells,” Developmental Neuroscience, vol. 15, no. 3–5, pp. 289–298, 1993. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Abe, H. Terakawa, M. Takanashi et al., “Proton magnetic resonance spectroscopy of patients with parkinsonism,” Brain Research Bulletin, vol. 52, no. 6, pp. 589–595, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. C. A. Guevara, C. R. Blain, D. Stahl, D. J. Lythgoe, P. N. Leigh, and G. J. Barker, “Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy,” European Journal of Neurology, vol. 17, no. 9, pp. 1193–1202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Federico, I. L. Simone, V. Lucivero et al., “Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes,” Italian Journal of Neurological Sciences, vol. 20, no. 4, pp. 223–229, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Watanabe, H. Fukatsu, M. Katsuno et al., “Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 75, no. 1, pp. 103–109, 2004. View at Google Scholar · View at Scopus
  41. A. Gröger, B. Bender, I. Wurster, G. L. Chadzynski, U. Klose, and D. Berg, “Differentiation between idiopathic and atypical parkinsonian syndromes using three-dimensional magnetic resonance spectroscopic imaging,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 84, no. 6, pp. 644–649, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. M. J. Firbank, R. M. Harrison, and J. T. O'Brien, “A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease,” Dementia and Geriatric Cognitive Disorders, vol. 14, no. 2, pp. 64–76, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Hattingen, J. Magerkurth, U. Pilatus et al., “Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease,” Brain, vol. 132, no. 12, pp. 3285–3297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Weiduschat, X. Mao, M. F. Beal, M. J. Nirenberg, D. C. Shungu, and C. Henchcliffe, “Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease,” Journal of Neuroimaging, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. B. A. Holshouser, M. Komu, H. E. Moller et al., “Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study,” Magnetic Resonance in Medicine, vol. 33, no. 5, pp. 589–594, 1995. View at Publisher · View at Google Scholar · View at Scopus
  46. C. M. Ellis, G. Lemmens, S. C. R. Williams et al., “Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study,” Neurology, vol. 49, no. 2, pp. 438–444, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Lucetti, P. Del Dotto, G. Gambaccini et al., “Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study,” Movement Disorders, vol. 22, no. 15, pp. 2170–2175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Llumiguano, N. Kovacs, Z. Usprung, A. Schwarcz, T. P. Dóczi, and I. Balas, “1H-MRS experiences after bilateral DBS of the STN in Parkinson's disease,” Parkinsonism & Related Disorders, vol. 14, no. 3, pp. 229–232, 2008. View at Publisher · View at Google Scholar · View at Scopus